Jen Christensen

6 days ago | flipboard.com | Jen Christensen

6 days ago | cnnbrasil.com.br | Jen Christensen

A farmacêutica Eli Lilly anunciou na quinta-feira (17) que uma versão experimental em comprimido dos populares medicamentos GLP-1 — como Mounjaro — ajudou pessoas com diabetes tipo 2 a perderem em média quase 8% do peso corporal após 40 semanas e reduziu seus níveis de hemoglobina glicada. A Lilly, que é fabricante do Mounjaro, medicamento para tratamento de diabetes, está entre várias empresas em busca de uma forma eficaz em comprimido dos análogos ao GLP-1.

1 week ago | wktv.com | Deidre McPhillips |Jen Christensen

(CNN) — Depression is becoming more common among adults and adolescents in the United States, but most are not getting therapy to help, according to a new report from the US Centers for Disease Control and Prevention. More than 1 in 8 people ages 12 and up in the US have been depressed in recent years, according to data published Wednesday by the CDC’s National Center for Health Statistics. Depression prevalence has nearly doubled, from 7.3% in 2015-16 to more than 13% in 2021-23.

1 week ago | cnn.com | Jen Christensen

CNN  —  Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 diabetes lose an average of nearly 8% of their body weight after 40 weeks and lowered their A1C levels. Lilly, which makes the injectable drugs Zepbound to treat obesity and Mounjaro and Trulicity to treat diabetes, is among several companies chasing an effective pill form of GLP-1s. The only such pill available so far comes with strict diet restrictions.

1 week ago | cnn.com | Deidre McPhillips |Jen Christensen

CNN  —  Depression is becoming more common among adults and adolescents in the United States, but most are not getting therapy to help, according to a new report from the US Centers for Disease Control and Prevention. More than 1 in 8 people ages 12 and up in the US have been depressed in recent years, according to data published Wednesday by the CDC’s National Center for Health Statistics. Depression prevalence has nearly doubled, from 7.3% in 2015-16 to more than 13% in 2021-23.